Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rhinitis in Asthma
ACTRN12606000095561Phase 2Recruiting
- Sponsor
- Woolcock Institute of Medical Research
- Start
- Mar 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of fluticasone in rhinitis and asthma (2 arms), sponsored by Woolcock Institute of Medical Research. Primary endpoints: Rhinitis-related quality of life and Subjective sleepiness. Started Mar 2006; status: recruiting.
02
Drugs
fluticasone
03
Conditions
rhinitisasthma
Beyond the preview
Go deeper on ACTRN12606000095561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12606000095561.